BioCryst (BCRX) Seeks to Correct Erroneous Patent on HCV Inhibitor
Go back to BioCryst (BCRX) Seeks to Correct Erroneous Patent on HCV Inhibitor| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 9.66 -0.41 (4.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.07 | 52 Week High | $10.98 | |||
| Open | $9.92 | 52 Week Low | $1.63 | |||
| Day High | $9.99 | P/E | N/A | |||
| Day Low | $9.60 | EPS | $-0.68 | |||
| Volume | 2,329,246 | |||||
